Reducing Recovery Time in Total Joint Arthroplasty

WEBINAR

Reducing Recovery Time in Total Joint Arthroplasty

Faculty: Alexander Sah, Gwo-Chin Lee, Lowry Barnes, Richard Berger

Notification icon This webinar took place on 
http://www.vumedi.com/webinar/reducing-recovery-time-in-total-joint-arthroplasty/
Sponsors

This activity is supported by an independent educational grant from

Program

Alexander Sah

Washington Hospital, Fremont, CA.

Enhancements in Pain Management Required for Reducing Length of Stay

Gwo-Chin Lee

University of Pennsylvania School of Medicine, Philadelphia, PA.

Avoiding Opioids in TJA

Lowry Barnes

University of Arkansas for Medical Sciences, Little Rock, AR.

Tracking Outcomes and Patient Satisfaction with Shorter Recovery

Richard Berger

Rush University Medical Center, Chicago, IL.

Considerations and Benefits for Starting an Outpatient TJA Program

Faculty:

  • Alexander Sah

    Washington Hospital, Fremont, CA.

  • Gwo-Chin Lee

    University of Pennsylvania School of Medicine, Philadelphia, PA.

  • Lowry Barnes

    University of Arkansas for Medical Sciences, Little Rock, AR.

  • Richard Berger

    Rush University Medical Center, Chicago, IL.

Release: 04/07/2015

Expiration: 04/14/2015

Location: Online

Requirements for successful completion: In order to receive credit, participants must view all audio-visual presentations and complete both the pre-test, post-test and evaluation form. Participants must score 100% on the activity post-test in order to receive credit. There are no pre-requisites for this activity. Course attendance verification forms are provided upon successful completion of the post-test and evaluation form. No partial credit will be given.

Target Audience: Physicians, residents and trainees, fellows, nurses, surgical techs, physical therapists, and other members of the allied health community whose scope of practice encompasses Orthopaedics.

Course Description: In this live webinar, expert Adult Reconstruction will present optimal operable techniques and treatment options to address Reducing Recovery Time in Total Joint Arthroplasty . The webinar features time for interactive audience discussion and surgical case based scenarios.

Learning Objectives: Upon completion of this activity, participants should be better able to discuss:

  1. Discuss enhancements in pain management required to reduce length of hospital stay
  2. Discuss the use of opioids in total joint arthroplasty
  3. Discuss tracking of outcomes and patient satisfaction with shorter recovery
  4. Discuss considerations and benefits for starting an outpatient TJA program

Credits: This lecture qualifies for 2 CME credit hours.

Cost: $0.0

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the The International Institute for Continuing Medical Education, Inc and VuMedi. The International Institute for Continuing Medical Education, Inc is accredited by the Accreditation Council for Continuing Medical Education to provide medical education to physicians.

Designation Statement: The International Institute for Continuing Medical Education, Inc designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosures: Faculty Disclosures/Conflict of Interest Policy\nIn accordance with ACCME requirements, The International Institute for Continuing Medical Education, Inc, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by The International Institute for Continuing Medical Education, Inc. and conflicts of interest were resolved prior to the activity.

Dr. Lowry Barnes discloses he has no relevant financial relationships with any commercial interests in relation to this activity.

Dr. Richard Berger discloses the following relevant financial relationships with a commercial interest: MicroPort: Paid consultant, Zimmer: IP royalties Small Bone Innovations: IP royalties

Dr. Gwo-Chin Lee discloses the following relevant financial relationships with a commercial interest: AAOS: Board or committee member, CD Diagnostics: Research support, Ceramtec: Paid presenter or speaker Clinical Orthopaedics and Related Research: Editorial or governing board, DePuy, A Johnson & Johnson Company: Paid consultant; Paid presenter or speaker, Iroko pharmaceuticals: Paid consultant, Journal of Arthroplasty: Editorial or governing board, Journal of Bone and Joint Surgery: Editorial or governing board, Mallinckrodt Pharmaceuticals: Paid consultant, Medtronic: Paid presenter or speaker, Orthopedics: Editorial or governing board, Pacira: Paid consultant, SLACK Incorporated: Editorial or governing board, Smith and Nephew: Research support, Stryker: Paid consultant, Zimmer: Research support.

Dr. Alexander Sah BaxterMedtronicAngiotechConvatec: Paid presenter or speaker Zimmer: Research support, Baxter Medtronic Angiotech Convatec: Paid presenter or speaker, Zimmer: Research support

Faculty Disclosures of Unlabeled Use: The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Dr. Lowry Barnes does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Richard Berger does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Gwo-Chin Lee does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Alexander Sah does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Commercial Support: No commercial support was received for this activity.

Software Requirements: VuMedi Webinars supports the following web browsers (with enabled JavaScript™): Internet Explorer® versions 6.0, 7.0, 8.0, Mozilla Firefox versions 1.0, 2.0, 3.0, and Safari for Mac. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. That software may be: Adobe Acrobat®, Adobe® Flash Player, Microsoft® Office PowerPoint, and Microsoft® Office Word.These activities will be marked as such and will provide links to the required software.

Copyright: Any and/or all materials are for the exclusive use of the faculty and participants of the live activity. Any copying, duplicating or reproducing of any and/or all materials by electronic, mechanical or other means for any purpose other than this enduring activity is strictly prohibited without prior written consent of the author of those materials.

Policy on Privacy and Confidentiality: For more information regarding VuMedi's Policy on Privacy and Confidentiality, please visit http://www.vumedi.com/pages/privacy/

To Contact our Accredited Provider: 6438 US Hwy 11
Springville, AL 35146
Phone: (205) 467-0290
Fax: (205) 467-0195
email: iicmemail@gmail.com

For questions regarding this activity, please contact VuMedi: cme@vumedi.com


8 Comments
Login to view comments. Click here to Login